Showing results (231-240 of 675) with videos related to

Sort By:
Pageof 68
Cancer|November 21, 2012
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancerSusan M Domchek, Komal Jhaveri, Sujata Patil, et al.
Breast Cancer Research : BCR|December 19, 2003
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatmentMark E Robson, Pierre O Chappuis, Jaya Satagopan, et al.
Genetic Epidemiology|October 6, 2005
Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mappingNathan A Ellis, Tomas Kirchhoff, Nandita Mitra, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 9, 2017
Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladderShaheen R Alanee, Sohela Shah, Emily C Zabor, et al.
Lancet (London, England)|July 9, 2010
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trialAndrew Tutt, Mark Robson, Judy E Garber, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer riskAllison W Kurian, Meredith A Mills, Margo Jaffee, et al.
JCO Oncology Practice|April 10, 2025
Video Education Is an Acceptable Alternative to Pretest Genetic Counseling for Patients With Breast, Ovarian, Pancreatic, and Metastatic Prostate Cancer: Results From a Randomized StudyKatherine A Schneider, Lauren Massingham, Michelle Weitz, et al.
Cancer Research|May 19, 2006
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent mannerGareth L Bond, Kim M Hirshfield, Tomas Kirchhoff, et al.
International Journal of Cancer|October 2, 2003
MSH6 germline mutations are rare in colorectal cancer familiesPaolo Peterlongo, Khedoudja Nafa, Gabriel S Lerman, et al.
Cancer Research|August 4, 2004
Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancersTari A King, Mary L Gemignani, Weiwei Li, et al.
Pageof 68